We’re excited to feature the latest research by Deidre Popovich, Helen Colby, and Tony Stovall, Ph.D., MBA, MS, published in Medical Decision Making! They conducted a series of experiments that showed when physician offices remind consumers of potential additional costs, this can lead to patients withholding their symptoms. Insurance information disclosures can discourage full communication between patients and physicians.
HealthCARE Lab的动态
最相关的动态
-
Thought-provoking article about how "listening to the patient" can be a vital contributor to positive therapeutic choices and outcomes. That is, if the listening and communication are purposeful and effective, and conducted by people who are skilled in the art. Overall, HCPs, Biopharma and AI companies have lots of room to continue to improve this aspect of care. Initiatives like StuffThatWorks seem expecially intriguing. #thepatientsvoice
Connecting the dots to uncover and cultivate cognitive connections that ignite life-saving transformations. Championing #lifescience #climatetech #digitalhealth and #healthinnovation.
The call to “listen to the patient’s voice” has echoed across the health ecosystem for decades. From clinicians to pharma leaders, this phrase has become a persistent rallying cry. But are we hearing what the patient has to say? Reality confirms we aren’t. My thoughts on why #realworldevidence is essential to improved patient care now on Medika Life. Yael Elish, StuffThatWorks; Stacy Hurt ??, Parexel, Advanced Clinical, The Marfan Foundation #patientexperience #RWE Decentralized Trials & Research Alliance (DTRA), Craig Lipset, Matt Veatch, Emily Epstein, LMSW, Weill Cornell Medicine
要查看或添加评论,请登录
-
?? Regulatory Updates Pertaining to Medical Device Companies Part II This newsletter summarizes important regulatory amendments (draft) and new review guidelines from the Ministry of Health and Welfare (MOHW) and the Health Insurance Review and Assessment Service (HIRA) that pertain to medical device companies. Companies planning to distribute products in Korea should consider the following information when establishing their market entry strategies. 1. Regulatory Revisions concerning Pre-Entry Tracks for Health Technologies ? Mandatory Informed Consent ? Usage Reporting Requirements ? Extended Assessment Deferral Period (2+2 System) ? Expanded Scope of Deferred Assessment Subjects ? Retroactive Application 2. Announcement of New HIRA Review Guidelines Check out the MDREX Newsletter for key highlights and implications. Click the link below for the newsletter! ?? ?? View Newsletter https://stib.ee/DByE ?? +82-2-2054-3458 ?? [email protected] ?? Subscribe to Newsletters → https://lnkd.in/diJ3j8A3
要查看或添加评论,请登录
-
Ambience Healthcare, founded by MIT alumni, automates documentation for clinicians before, during, and after patient visits. The founders say clinicians using Ambience save time on documentation, report lower levels of burnout, and develop higher-quality relationships with their patients. #efficiency #productivity #quality #costreduction
要查看或添加评论,请登录
-
In the current medical climate, traditional practices often resort to prescribing medications quickly due to time constraints and insurance reimbursement models that incentivize this approach. In this clip, Dr. Randy Pardue notes that lifestyle medicine, while incredibly effective, requires more time and hands-on coaching, which sadly isn't adequately rewarded by the traditional reimbursement system. This is yet another reason why I love the cash-only model in medicine. It allows for more time to be spent with the patient.
要查看或添加评论,请登录
-
https://lnkd.in/gcS_fym7 The good news just keeps coming...... IN THE UNITED STATES, INSURERS PROJECT A 10.2% INCREASE IN 2025, UP FROM 9.3% THIS YEAR “With medical cost increases remaining at double-digit levels, employers will need to manage budget expectations and balance cost increases with data-driven business and health outcomes. The seemingly never-ending rise in costs poses a constant challenge for employers to take action in order to mitigate these unsustainable increases.” The icing on the cake..... "Moreover, no cost relief is on the immediate horizon. Although the trend may be slightly cooling in some regions, it is projected to remain elevated over the longer term. Over the next three years, nearly two-thirds of insurers anticipate higher or significantly higher medical cost trends globally." ***For those of you who remember it, the "Rule of 72" says that at 9.3% increase YoY means your costs DOUBLE in 7.74 years. At a 10.2% increase - you double in 7.05 years. Can you or your employer clients sustain the DOUBLING of your costs in the next 7 years??? Of course not. Are you thinking of partnering with another BUCA ASO or PPO and a traditional PBM model, again?? - You do know that those models make more $ when the Plan spends more money, right? Hence that model's 40+ year track record of 100% failure in controlling costs. To control costs, you MUST think out of the box. We have been doing that for almost 20 years, and our clients' plans show a lot of success in significantly decreasing costs. We are here to help. Reach out and let's talk.
要查看或添加评论,请登录
-
You’re not overwhelmed, you just need guidance. ?? At Neutra Life Sciences, we're exploring cutting-edge medical treatments through clinical trials, offering hope and solutions for everyone, with or without insurance. Our patient-centric approach ensures top-notch care and transparency. Discover how you can be part of these advancements. Contact us at: - [email protected] - +2815980200 Share this to spread awareness! #ClinicalTrials #MedicalAdvancements #clinicalresearch
要查看或添加评论,请登录
-
-
Atlantic Health System Deploys Tech to Better Manage Polypharmacy Patients – MedCity News - MedCity News #AtlanticHealthSystem #PolypharmacyManagement #HealthcareTechnology Atlantic Health System has implemented new technology to improve the management of polypharmacy patients. The system uses advanced algorithms to analyze medication data and identify potential drug interactions and adverse effects. This technology helps healthcare providers make informed decisions about medication management for patients with complex medication regimens. #Benefits of Technology in Polypharmacy Management The use of technology in polypharmacy management has several benefits, including improved patient safety, reduced medication errors, and enhanced coordination of care. By leveraging data analytics and decision support tools, healthcare providers can optimize medication therapy and improve outcomes for polypharmacy patients. #Challenges in Polypharmacy Management Despite the benefits of technology, there are challenges in ai.mediformatica.com #health #better #feelbetter #medication #management #patients #medicationmanagement #atlantichealthsystem #platform #startup #technology #pharmacy #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3xz3O4J)
要查看或添加评论,请登录
-
The landscape of medicine is undergoing significant challenges, making it increasingly difficult to practice. Physicians are facing declining reimbursement rates year after year, while the cost of practicing medicine continues to rise. From higher malpractice insurance premiums and administrative burdens to the expense of maintaining cutting-edge technology and compliance with regulatory requirements, the financial pressures are mounting. This imbalance between decreasing income and increasing overhead not only threatens the sustainability of medical practices but also impacts patient care as resources are stretched thinner. The profession requires urgent reforms to ensure that doctors can continue to provide quality care while maintaining the financial viability of their practices. Thoughts? Where do you see medicine in the next 5 years? www.antoniowebbmd.com
要查看或添加评论,请登录
-
Healthcare data de-identification provides significant opportunities to bolster medical research and patient care, but the process is not without its pitfalls.
要查看或添加评论,请登录
-
Continued medical Innovation makes us all better off. Market-based pricing encourages investment in new cures, and expiring patents ensure future generations benefit from inexpensive generics, permanently upgrading human health. Society ought to pay for them together without burdening those who need them today with high out-of-pocket costs. https://lnkd.in/eVYzX8-C
要查看或添加评论,请登录